Robert B. Perni

5.6k total citations
49 papers, 2.4k citations indexed

About

Robert B. Perni is a scholar working on Molecular Biology, Organic Chemistry and Epidemiology. According to data from OpenAlex, Robert B. Perni has authored 49 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 16 papers in Organic Chemistry and 14 papers in Epidemiology. Recurrent topics in Robert B. Perni's work include Hepatitis C virus research (14 papers), Hepatitis B Virus Studies (9 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Robert B. Perni is often cited by papers focused on Hepatitis C virus research (14 papers), Hepatitis B Virus Studies (9 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Robert B. Perni collaborates with scholars based in United States, China and United Kingdom. Robert B. Perni's co-authors include Ann D. Kwong, Chao Lin, Kai Lin, Han Dai, Robert K. Boeckman, Yu-Ping Luong, Cynthia A. Gates, David P. Carney, Yunyi Wei and Lei Jin and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Hepatology.

In The Last Decade

Robert B. Perni

49 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert B. Perni United States 23 988 868 684 609 506 49 2.4k
Thomas E. Spratt United States 27 162 0.2× 54 0.1× 90 0.1× 1.2k 2.0× 166 0.3× 62 1.7k
Francis X. Wilson United Kingdom 26 138 0.1× 84 0.1× 18 0.0× 1.2k 1.9× 1.4k 2.8× 65 2.1k
Charles Grubmeyer United States 28 740 0.7× 7 0.0× 438 0.6× 3.1k 5.1× 136 0.3× 62 3.7k
Youcef Mehellou United Kingdom 20 283 0.3× 83 0.1× 7 0.0× 1.1k 1.7× 485 1.0× 40 1.9k
Joel Bard United States 14 113 0.1× 118 0.1× 15 0.0× 768 1.3× 150 0.3× 17 1.2k
Sungman Cha United States 27 312 0.3× 32 0.0× 9 0.0× 2.1k 3.4× 240 0.5× 55 2.9k
Jean‐François Guichou France 23 124 0.1× 36 0.0× 20 0.0× 967 1.6× 227 0.4× 62 1.7k
Paul D. van Poelje United States 23 352 0.4× 123 0.1× 5 0.0× 1.1k 1.8× 414 0.8× 33 2.1k
Charles A. McWherter United States 27 298 0.3× 129 0.1× 5 0.0× 960 1.6× 170 0.3× 55 1.6k
James M. Fujitaki United States 18 267 0.3× 97 0.1× 4 0.0× 585 1.0× 132 0.3× 34 1.2k

Countries citing papers authored by Robert B. Perni

Since Specialization
Citations

This map shows the geographic impact of Robert B. Perni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert B. Perni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert B. Perni more than expected).

Fields of papers citing papers by Robert B. Perni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert B. Perni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert B. Perni. The network helps show where Robert B. Perni may publish in the future.

Co-authorship network of co-authors of Robert B. Perni

This figure shows the co-authorship network connecting the top 25 collaborators of Robert B. Perni. A scholar is included among the top collaborators of Robert B. Perni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert B. Perni. Robert B. Perni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dai, Han, David P. Carney, April Case, et al.. (2010). SIRT1 Activation by Small Molecules. Journal of Biological Chemistry. 285(43). 32695–32703. 175 indexed citations
2.
Blum, Charles A., James L. Ellis, Christine Loh, et al.. (2010). SIRT1 Modulation as a Novel Approach to the Treatment of Diseases of Aging. Journal of Medicinal Chemistry. 54(2). 417–432. 65 indexed citations
3.
Vu, Chi B., Jean E. Bemis, Jeremy S. Disch, et al.. (2009). Discovery of Imidazo[1,2- b ]thiazole Derivatives as Novel SIRT1 Activators. Journal of Medicinal Chemistry. 52(5). 1275–1283. 101 indexed citations
4.
Vu, Chi B., Jill C. Milne, David P. Carney, et al.. (2009). Discovery of benzothiazole derivatives as efficacious and enterocyte-specific MTP inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(5). 1416–1420. 23 indexed citations
5.
Perni, Robert B., Gurudatt Chandorkar, Kevin M. Cottrell, et al.. (2007). Inhibitors of hepatitis C virus NS3·4A protease. Effect of P4 capping groups on inhibitory potency and pharmacokinetics. Bioorganic & Medicinal Chemistry Letters. 17(12). 3406–3411. 16 indexed citations
6.
Thomson, John A. & Robert B. Perni. (2006). Hepatitis C virus NS3-4A protease inhibitors: countering viral subversion in vitro and showing promise in the clinic.. PubMed. 9(5). 606–17. 17 indexed citations
7.
Lin, Chao, Ann D. Kwong, & Robert B. Perni. (2006). Discovery and Development of VX-950, a Novel, Covalent, and Reversible Inhibitor of Hepatitis C Virus NS3.4A Serine Protease. Infectious Disorders - Drug Targets. 6(1). 3–16. 166 indexed citations
8.
Lin, Chao, Cynthia A. Gates, B. Govinda Rao, et al.. (2005). In Vitro Studies of Cross-resistance Mutations against Two Hepatitis C Virus Serine Protease Inhibitors, VX-950 and BILN 2061. Journal of Biological Chemistry. 280(44). 36784–36791. 170 indexed citations
9.
Perni, Robert B., J. PITLIK, John J. Court, et al.. (2004). Inhibitors of hepatitis C virus NS3·4A protease 2. Warhead SAR and optimization. Bioorganic & Medicinal Chemistry Letters. 14(6). 1441–1446. 41 indexed citations
10.
Lin, Chao, Kai Lin, Yu-Ping Luong, et al.. (2004). In Vitro Resistance Studies of Hepatitis C Virus Serine Protease Inhibitors, VX-950 and BILN 2061. Journal of Biological Chemistry. 279(17). 17508–17514. 228 indexed citations
11.
Perni, Robert B., Lawrence F. Courtney, David D. Deininger, et al.. (2003). Inhibitors of hepatitis C virus NS3·4A protease 1. Non-Charged tetrapeptide variants. Bioorganic & Medicinal Chemistry Letters. 13(22). 4059–4063. 25 indexed citations
12.
Perni, Robert B. & Ann D. Kwong. (2002). 5 Inhibitors of Hepatitis C Virus NS3•4A Protease: An Overdue Line of Therapy. Progress in medicinal chemistry. 39. 215–255. 12 indexed citations
13.
Perni, Robert B., et al.. (2000). Phenylpropenamide derivatives as inhibitors of Hepatitis B virus replication. Bioorganic & Medicinal Chemistry Letters. 10(23). 2687–2690. 65 indexed citations
14.
Perni, Robert B.. (2000). NS3. A protease as a target for interfering with hepatitis C virus replication. Drug News & Perspectives. 13(2). 69–69. 9 indexed citations
15.
Reuman, Michael, Sol J. Daum, Baldev Singh, et al.. (1995). Synthesis and Antibacterial Activity of Some Novel 1-Substituted 1,4-Dihydro-4-oxo-7-pyridinyl-3-quinolinecarboxylic Acids. Potent Antistaphylococcal Agents. Journal of Medicinal Chemistry. 38(14). 2531–2540. 21 indexed citations
16.
Wentland, Mark P., J. Andrew Carlson, Peter H. Dorff, et al.. (1995). Cyclic Variations of 3-Quinolinecarboxamides and Effects on Antiherpetic Activity. Journal of Medicinal Chemistry. 38(14). 2541–2545. 4 indexed citations
17.
Wentland, Mark P., Robert B. Perni, Allan G. Hlavac, et al.. (1994). Anti-solid tumor efficacy and preparation of N-[[1-[[2-(diethylamino)ethyl]amino]-9-oxo-9H-thioxanthen-4-yl]methyl]methanesulfonamide (win 33377) and related derivatives. Bioorganic & Medicinal Chemistry Letters. 4(4). 609–614. 21 indexed citations
18.
Wentland, Mark P., Robert B. Perni, Peter H. Dorff, et al.. (1993). 3-Quinolinecarboxamides. A series of novel orally-active antiherpetic agents. Journal of Medicinal Chemistry. 36(11). 1580–1596. 31 indexed citations
19.
Wentland, Mark P., Robert B. Perni, Peter H. Dorff, & James Rake. (1988). Synthesis and bacterial DNA gyrase inhibitory properties of a spirocyclopropylquinolone derivative. Journal of Medicinal Chemistry. 31(9). 1694–1697. 19 indexed citations
20.
Boeckman, Robert K. & Robert B. Perni. (1986). Studies directed toward the synthesis of naturally occurring acyltetramic acids. 2. Preparation of the macrocyclic subunit of ikarugamycin. The Journal of Organic Chemistry. 51(26). 5486–5489. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas E. Spratt Breakdown of academic impact, for papers by Francis X. Wilson Breakdown of academic impact, for papers by Charles Grubmeyer Breakdown of academic impact, for papers by Youcef Mehellou Breakdown of academic impact, for papers by Joel Bard Breakdown of academic impact, for papers by Sungman Cha Breakdown of academic impact, for papers by Jean‐François Guichou Breakdown of academic impact, for papers by Paul D. van Poelje Breakdown of academic impact, for papers by Charles A. McWherter Breakdown of academic impact, for papers by James M. Fujitaki
Rankless by CCL
2026